These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 28235409)

  • 41. Vincristine induces cell cycle arrest and apoptosis in SH-SY5Y human neuroblastoma cells.
    Tu Y; Cheng S; Zhang S; Sun H; Xu Z
    Int J Mol Med; 2013 Jan; 31(1):113-9. PubMed ID: 23129065
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isatin inhibits proliferation and induces apoptosis of SH-SY5Y neuroblastoma cells in vitro and in vivo.
    Song J; Hou L; Ju C; Zhang J; Ge Y; Yue W
    Eur J Pharmacol; 2013 Feb; 702(1-3):235-41. PubMed ID: 23376416
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epigenetic modulation of retinoic acid receptor beta2 by the histone deacetylase inhibitor MS-275 in human renal cell carcinoma.
    Wang XF; Qian DZ; Ren M; Kato Y; Wei Y; Zhang L; Fansler Z; Clark D; Nakanishi O; Pili R
    Clin Cancer Res; 2005 May; 11(9):3535-42. PubMed ID: 15867257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HDAC Inhibition for the Treatment of Epithelioid Sarcoma: Novel Cross Talk Between Epigenetic Components.
    Lopez G; Song Y; Lam R; Ruder D; Creighton CJ; Bid HK; Bill KL; Bolshakov S; Zhang X; Lev D; Pollock RE
    Mol Cancer Res; 2016 Jan; 14(1):35-43. PubMed ID: 26396249
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA-141 and its associated gene FUS modulate proliferation, migration and cisplatin chemosensitivity in neuroblastoma cell lines.
    Wang Z; Lei H; Sun Q
    Oncol Rep; 2016 May; 35(5):2943-51. PubMed ID: 26936280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The HDACi Panobinostat Shows Growth Inhibition Both In Vitro and in a Bioluminescent Orthotopic Surgical Xenograft Model of Ovarian Cancer.
    Helland Ø; Popa M; Bischof K; Gjertsen BT; McCormack E; Bjørge L
    PLoS One; 2016; 11(6):e0158208. PubMed ID: 27352023
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thioether-based 2-aminobenzamide derivatives: Novel HDAC inhibitors with potent in vitro and in vivo antitumor activity.
    Yun F; Cheng C; Ullah S; He J; Zahi MR; Yuan Q
    Eur J Med Chem; 2019 Aug; 176():195-207. PubMed ID: 31103900
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
    Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
    Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel MDM2 inhibitor SAR405838 (MI-773) induces p53-mediated apoptosis in neuroblastoma.
    Lu J; Guan S; Zhao Y; Yu Y; Wang Y; Shi Y; Mao X; Yang KL; Sun W; Xu X; Yi JS; Yang T; Yang J; Nuchtern JG
    Oncotarget; 2016 Dec; 7(50):82757-82769. PubMed ID: 27764791
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells.
    Nishioka C; Ikezoe T; Yang J; Koeffler HP; Yokoyama A
    Leukemia; 2008 Dec; 22(12):2159-68. PubMed ID: 18784743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts.
    Croucher JL; Iyer R; Li N; Molteni V; Loren J; Gordon WP; Tuntland T; Liu B; Brodeur GM
    Cancer Chemother Pharmacol; 2015 Jan; 75(1):131-41. PubMed ID: 25394774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel ALK inhibitor AZD3463 inhibits neuroblastoma growth by overcoming crizotinib resistance and inducing apoptosis.
    Wang Y; Wang L; Guan S; Cao W; Wang H; Chen Z; Zhao Y; Yu Y; Zhang H; Pang JC; Huang SL; Akiyama Y; Yang Y; Sun W; Xu X; Shi Y; Zhang H; Kim ES; Muscal JA; Lu F; Yang J
    Sci Rep; 2016 Jan; 6():19423. PubMed ID: 26786851
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anticancer activity of MS-275, a novel histone deacetylase inhibitor, against human endometrial cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Anticancer Res; 2006; 26(2A):939-45. PubMed ID: 16619490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MS275 enhances cytotoxicity induced by 5-fluorouracil in the colorectal cancer cells.
    Flis S; Gnyszka A; Flis K; Spławiński J
    Eur J Pharmacol; 2010 Feb; 627(1-3):26-32. PubMed ID: 19853597
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activating Transcription Factor 3 Expression as a Marker of Response to the Histone Deacetylase Inhibitor Pracinostat.
    Sooraj D; Xu D; Cain JE; Gold DP; Williams BR
    Mol Cancer Ther; 2016 Jul; 15(7):1726-39. PubMed ID: 27196751
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting carbonic anhydrase IX with small organic ligands.
    Wichert M; Krall N
    Curr Opin Chem Biol; 2015 Jun; 26():48-54. PubMed ID: 25721398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives.
    Ahlskog JK; Dumelin CE; Trüssel S; Mårlind J; Neri D
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4851-6. PubMed ID: 19615903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Favorable neuroblastoma genes and molecular therapeutics of neuroblastoma.
    Tang XX; Robinson ME; Riceberg JS; Kim DY; Kung B; Titus TB; Hayashi S; Flake AW; Carpentieri D; Ikegaki N
    Clin Cancer Res; 2004 Sep; 10(17):5837-44. PubMed ID: 15355914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antitumor Activity of a Novel Sphingosine-1-Phosphate 2 Antagonist, AB1, in Neuroblastoma.
    Li MH; Swenson R; Harel M; Jana S; Stolarzewicz E; Hla T; Shapiro LH; Ferrer F
    J Pharmacol Exp Ther; 2015 Sep; 354(3):261-8. PubMed ID: 26105954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Histone deacetylase inhibition induces apoptosis and autophagy in human neuroblastoma cells.
    Francisco R; Pérez-Perarnau A; Cortés C; Gil J; Tauler A; Ambrosio S
    Cancer Lett; 2012 May; 318(1):42-52. PubMed ID: 22186300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.